Languages: en  fr 

Shareholder information

Listings

  • NYSE Euronext Paris (IPO on 24.10.1997)
  • Frankfurter Wertpapierbörse / XETRA Frankfurt (SPO on 26.10.2000)

Our Euronext page can be found here

Segments/ Indexes

  • Paris: Next 150 & SBF 250, Next Biotech, SRD and Compartiment B,
  • Frankfurt: Prime Standard/ Technology All Share

Industry Group/ Prime Sector

  • Pharma & Healthcare/Healthcare Providers

Codes

  • ISIN: FR 0000038259
  • Paris: Euronext FR 0000038259
  • Frankfurt: WKN 910251

Tickers

  • Paris: Reuters EUFI.LN, Bloomberg ERF FP
  • Frankfurt: ESF, EUFI.DE

Nominal Capital (at 31.03.2010)

  • €1,420,487.40 (14,204,874 shares x 0.10€)

Dividend

  • A dividend of €0.10 per share for the year 2009 was approved by the board at the 2010 AGM and paid on 13th July 2010
  • Eurofins does not plan to increase the dividend in the foreseeable future

Simplified Ownership Structure

  • 53% Free Float
  • 47% Analytical Bioventures SCA (holding of the Martin family)

Share-price Development

Eurofins share price since the IPO in 1997 is one of the best performing in Europe

Investor Relations